← Open Payments lookup

RACHEL HOANG: Open Payments

NPI 1497495196 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$472 in 13 payments from 10 companies in 2025. Trend: 2023 $432 · 2024 $606 · 2025 $472

Food & beverage: $472
CompanyPaymentsAmount
Amgen Inc.2$152
Teva Pharmaceuticals USA, Inc.1$122
Novo Nordisk Inc3$59
Optinose US, Inc.1$31
GlaxoSmithKline, LLC.1$22
AstraZeneca Pharmaceuticals LP1$21
Novartis Pharmaceuticals Corporation1$19
IBSA Pharma Inc.1$17
Lilly USA, LLC1$15
Exact Sciences Corporation1$14

Products named: TEPEZZA, Xhance, TRELEGY ELLIPTA, AIRSUPRA, LEQVIO, Tirosint, MOUNJARO, Ozempic.

Industry payments across TX — which companies pay providers there.